Prevalence of Co-Infections with Respiratory Viruses in Individuals Investigated for SARS-CoV-2 in Ontario, Canada
- PMID: 33477649
- PMCID: PMC7831481
- DOI: 10.3390/v13010130
Prevalence of Co-Infections with Respiratory Viruses in Individuals Investigated for SARS-CoV-2 in Ontario, Canada
Abstract
Background: Co-infections of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with respiratory viruses, bacteria and fungi have been reported to cause a wide range of illness.
Objectives: We assess the prevalence of co-infection of SARS-CoV-2 with seasonal respiratory viruses, document the respiratory viruses detected among individuals tested for SARS-CoV-2, and describe characteristics of individuals with respiratory virus co-infection detected.
Methods: Specimens included in this study were submitted as part of routine clinical testing to Public Health Ontario Laboratory from individuals requiring testing for SARS-CoV-2 and/or seasonal respiratory viruses.
Results: Co-infection was detected in a smaller proportion (2.5%) of individuals with laboratory confirmed SARS-CoV-2 than those with seasonal respiratory viruses (4.3%); this difference was not significant. Individuals with any respiratory virus co-infection were more likely to be younger than 65 years of age and male than those with single infection. Those with SARS-CoV-2 co-infection manifested mostly mild respiratory symptoms.
Conclusions: Findings of this study may not support routine testing for seasonal respiratory viruses among all individuals tested for SARS-CoV-2, as they were rare during the study period nor associated with severe disease. However, testing for seasonal respiratory viruses should be performed in severely ill individuals, in which detection of other viruses may assist with patient management.
Keywords: COVID-19; SARS-CoV-2; co-infection; seasonal respiratory viruses.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures

References
-
- WHO Rolling Updates on Coronavirus Disease (COVID-19) [(accessed on 22 April 2020)]; Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-a....
-
- Chung H., Fung K., Ferreira-Legere L.E., Chen B., Ishiguro L., Kalappa G., Campell T., Paterson J.M., Bronskill S.E., Kwong J.C., et al. COVID-19 Laboratory Testing in Ontario: Patterns of Testing and Characteristics of Individuals Tested as of April 30, 2020. ICES; Toronto, ON, Canada: 2020. [(accessed on 5 June 2020)]. Available online: https://www.ices.on.ca/Publications/Atlases-and-Reports/2020/COVID-19-La....
-
- WHO Coronavirus Disease (COVID-19) Situation Report-123. [(accessed on 3 May 2020)]; Available online: https://www.who.int/docs/default-source/coronaviruse/situation-reports/2....
-
- Bordi L., Nicastri E., Scorzolini L., Di Caro A., Capobianchi M.R., Concetta C., Lalle E. INMI COVID-19 study group and Collaborating Centers. Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020. Euro Surveill. 2020 doi: 10.2807/1560-7917.ES.2020.25.8.2000170. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous